Skip to content

Warby Parker WRBY Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$248.78M+55.4%

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's common stock shares outstanding?
Warby Parker (WRBY) reported common stock shares outstanding of $25.29M in Q1 2026.
How has Warby Parker's common stock shares outstanding changed year-over-year?
Warby Parker's common stock shares outstanding increased by 19.9% year-over-year, from $21.1M to $25.29M.
What is the long-term trend for Warby Parker's common stock shares outstanding?
Over 5 years (2020 to 2025), Warby Parker's common stock shares outstanding has grown at a -23.9% compound annual growth rate (CAGR), from $103.82M to $26.48M.
What does common stock shares outstanding mean?
This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.